Table 1.
The association of HLA-G expression with clinicopathological status was analyzed by Chi-squared tests.
| HLA-G |
||||
|---|---|---|---|---|
| Clinicopathological parameters | Low N = 64 | High N = 38 | p value | |
| Age (32–83) | 56 ± 11 | 55 ± 11 | ||
| Menopausal status | pre | 26 | 14 | 0.7 |
| post | 38 | 24 | ||
| Nuclear grade | 1 | 27 | 10 | 0.25 |
| 2 | 34 | 25 | ||
| 3 | 3 | 3 | ||
| Lymphatic duct invasion (ly) | − | 46 | 24 | 9.36 |
| + | 18 | 14 | ||
| Vascular invasion (v) | − | 42 | 31 | 0.08 |
| + | 22 | 7 | ||
| Pathological T | T1 | 52 | 28 | 0.14 |
| T2 | 9 | 10 | ||
| T3 | 3 | 0 | ||
| Lymph node metastasis | − | 46 | 22 | 0.14 |
| + | 18 | 16 | ||
| Pathological Stage | I | 41 | 18 | 0.2 |
| II | 19 | 18 | ||
| III | 4 | 2 | ||
| ER | − | 6 | 11 | 0.01 |
| + | 58 | 27 | ||
| PR | − | 12 | 16 | 0.01 |
| + | 52 | 22 | ||
| HER2 | − | 56 | 30 | 0.25 |
| + | 8 | 8 | ||